| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/24/2010 | US20100160402 Bisbenzimidazoles as antimalarial agents |
| 06/24/2010 | US20100160401 4-phenylimidazole-2-thione tyrosinase inhibitors and treatment or prevention of pigmentary disorders therewith |
| 06/24/2010 | US20100160400 Treatment using dantrolene |
| 06/24/2010 | US20100160398 Farnesoid X Receptor Agonists |
| 06/24/2010 | US20100160397 Oxazole derivatives and their use in the treatment of diabetes and obesity |
| 06/24/2010 | US20100160395 Cyclopropyl compounds |
| 06/24/2010 | US20100160394 Use of 4-[(4- thiazolyl)phenoxy]alkoxy-benzamidine derivatives for the prophylaxis and treatment of osteoporosis |
| 06/24/2010 | US20100160393 Crystal form of epothilone b and use in pharmaceutical compositions |
| 06/24/2010 | US20100160392 Histone deacetylase inhibitors |
| 06/24/2010 | US20100160391 Substituted Aminopyridines as Fluorescent Reporters for Amide Hydrolases |
| 06/24/2010 | US20100160390 Compounds capable of activating cholinergic receptors |
| 06/24/2010 | US20100160389 Dihydropyridone amidesas p2x7 modulators |
| 06/24/2010 | US20100160388 Dihydropyridone ureas as p2x7 modulators |
| 06/24/2010 | US20100160387 Dihydropyridone amides as p2x7 modulators |
| 06/24/2010 | US20100160386 4-phenoxy-nicotine acid derivatives and use thereof as ppar-modulators |
| 06/24/2010 | US20100160384 Dihydropyridone amides as p2x7 modulators |
| 06/24/2010 | US20100160383 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation |
| 06/24/2010 | US20100160382 Anti-acid pharmaceutical composition in powder form and process for making it |
| 06/24/2010 | US20100160381 RAF Inhibitors for the Treatment of Thyroid Cancer |
| 06/24/2010 | US20100160380 Therapeutic Salt Compositions and Methods |
| 06/24/2010 | US20100160379 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof |
| 06/24/2010 | US20100160378 Compositions for drug administration |
| 06/24/2010 | US20100160377 Derivatives of pyrazole 3,5-carboxylates, their preparation and their application in therapeutics |
| 06/24/2010 | US20100160376 Nicotine-alternative compositions and methods of producing such compositions |
| 06/24/2010 | US20100160375 Methods and compositions for treating infections comprising a local anesthetic |
| 06/24/2010 | US20100160374 N-(2-Hydroxyethyl)-N-Methyl-4-(Quinolin-8-yl(1-(Thiazol-4-ylmethyl)Piperidin-4-ylidene)Methyl)Benzamide |
| 06/24/2010 | US20100160373 Dihydropyridone amides as p2x7 modulators |
| 06/24/2010 | US20100160372 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 06/24/2010 | US20100160371 Inhibition of p38 kinase activity by aryl ureas |
| 06/24/2010 | US20100160370 Method of treatment and pharmaceutical compositions |
| 06/24/2010 | US20100160369 S1P1 Agonists and Methods of Making And Using |
| 06/24/2010 | US20100160368 Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy |
| 06/24/2010 | US20100160367 Pharmaceutical compositions containing pyrroloquinoline quinone and nephroprotectant for treating ischemia reperfusion injuries |
| 06/24/2010 | US20100160366 Treatment method |
| 06/24/2010 | US20100160365 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 06/24/2010 | US20100160364 Remedy or preventive for integration dysfunction syndrome |
| 06/24/2010 | US20100160363 Extended-release pharmaceutical formulations |
| 06/24/2010 | US20100160362 Spiro (furo [3, 2-c] pyridine-3-3' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain |
| 06/24/2010 | US20100160361 Treatment of major adverse cardiac events and acute coronary syndrome using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapies |
| 06/24/2010 | US20100160360 Jnk modulators |
| 06/24/2010 | US20100160359 Modulators of Metabolism and the Treatment of Disorders Related Thereto |
| 06/24/2010 | US20100160358 Pyridylsulfonamidyl-Pyrimidines for the Prevention of Blood Vessel Graft Failure |
| 06/24/2010 | US20100160357 Heterobicyclic sphingosine 1-phosphate analogs |
| 06/24/2010 | US20100160356 Novel cyclobutyl compounds as kinase inhibitors |
| 06/24/2010 | US20100160355 Anti-Viral Compounds |
| 06/24/2010 | US20100160354 Novel compounds |
| 06/24/2010 | US20100160353 Pharmaceutical composition and beverage composition comprising l-arginine |
| 06/24/2010 | US20100160352 Adenine derivatives |
| 06/24/2010 | US20100160351 Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| 06/24/2010 | US20100160350 Pyrazolopyrimidinone kinase inhibitor |
| 06/24/2010 | US20100160349 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 06/24/2010 | US20100160348 Materials and methods for detecting and treating peritoneal ovarian tumor dissemination involving tissue transglutaminase |
| 06/24/2010 | US20100160347 PYRIDO[1,2-a]PYRIMIDIN-4-ONE INHIBITORS OF MAST CELL DEGRANULATION |
| 06/24/2010 | US20100160346 Neurologically active compounds |
| 06/24/2010 | US20100160345 Novel compounds |
| 06/24/2010 | US20100160344 Novel compounds |
| 06/24/2010 | US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160342 Compositions of Topical Ocular Solutions to Deliver Effective Concentrations of Active Agent to the Posterior Segment of the Eye |
| 06/24/2010 | US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160340 Protein kinase inhibitors |
| 06/24/2010 | US20100160339 Treating pancreatitis |
| 06/24/2010 | US20100160338 Benzenesulfonamide modulators of alpha-1a adrenergic receptors |
| 06/24/2010 | US20100160337 Sulfamides as trpm8 modulators |
| 06/24/2010 | US20100160336 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors |
| 06/24/2010 | US20100160335 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 06/24/2010 | US20100160334 Tricyclic anilide spirolactam cgrp receptor antagonists |
| 06/24/2010 | US20100160333 Novel 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/24/2010 | US20100160332 a2-Adrenoceptor Ligands |
| 06/24/2010 | US20100160331 Novel carbamoyloxy arylalkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
| 06/24/2010 | US20100160330 Novel bicyclic heterocycles useful as selective androgen receptor modulators |
| 06/24/2010 | US20100160329 Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases |
| 06/24/2010 | US20100160328 New compounds useful for dpp-iv enzyme inhibition |
| 06/24/2010 | US20100160327 Modified Malonate Derivatives |
| 06/24/2010 | US20100160325 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 06/24/2010 | US20100160324 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
| 06/24/2010 | US20100160323 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 06/24/2010 | US20100160322 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 06/24/2010 | US20100160321 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase |
| 06/24/2010 | US20100160320 C5aR ANTAGONISTS |
| 06/24/2010 | US20100160319 Histamine h3 receptor agents, preparation and therapeutic uses |
| 06/24/2010 | US20100160318 3-Pyrrolo[b]Cyclohexylene-2-Dihydroindolinone Derivatives and Uses Thereof |
| 06/24/2010 | US20100160317 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl-propyl)-6,7-dihydro-1h-pyrrol[3,2-c]pyridine-4(5h)-one compounds and use as protein kinase inhibitors |
| 06/24/2010 | US20100160316 Quinazolines useful as modulators of ion channels |
| 06/24/2010 | US20100160315 Novel 2, 3-diamino-quinazolinone derivatives and their medical use |
| 06/24/2010 | US20100160314 Small Molecule Inhibitors of Toll-Like Receptor 9 |
| 06/24/2010 | US20100160313 Discovery of novel anticancer compounds based on conformational sampling of quinoxalinhydrazide pharmacophore |
| 06/24/2010 | US20100160312 Substituted Pyridone Compounds and Methods of Use |
| 06/24/2010 | US20100160310 2,4 (4,6) pyrimidine derivatives |
| 06/24/2010 | US20100160309 Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1 |
| 06/24/2010 | US20100160308 Thiazolyl-Benzimidazoles |
| 06/24/2010 | US20100160307 Method for controlling particular insect pests by applying anthranilamide compounds |
| 06/24/2010 | US20100160306 Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists |
| 06/24/2010 | US20100160305 3, 4, 5 - Substituted Piperidine Compounds |
| 06/24/2010 | US20100160304 Aromatic sulfone compound as aldosterone receptor modulator |
| 06/24/2010 | US20100160303 Carbazole carboxamide compounds useful as kinase inhibitors |
| 06/24/2010 | US20100160302 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 06/24/2010 | US20100160301 Microangiopathy treatment and prevention |
| 06/24/2010 | US20100160300 Method of Treating Depression |
| 06/24/2010 | US20100160299 Dendrimer conjugates |
| 06/24/2010 | US20100160298 Method of treating ocular allergy |